Back to News
Market Impact: 0.25

Prysmian: Hyperscaler Capex Keeps The Buy Case Alive Despite A 300% Rally

Technology & InnovationCorporate EarningsCorporate Guidance & OutlookM&A & RestructuringCredit & Bond MarketsCompany FundamentalsAnalyst Insights
Prysmian: Hyperscaler Capex Keeps The Buy Case Alive Despite A 300% Rally

Prysmian is expected to benefit from hyperscaler CAPEX, with Digital Solutions delivering 9% organic growth and 20.6% EBITDA margins. Management points to earnings upside via margin expansion, supported by strong free cash flow and deleveraging to below 1.0x ND/EBITDA by 2026, alongside potential M&A capacity. Despite a higher valuation, the note flags upside to 2027 estimates, keeping a “buyers” stance.

Analysis

The market is still underestimating how scarce qualified cable capacity is becoming in the AI buildout. This is not a normal top-line beta story: when hyperscaler demand outruns installed capacity, the supplier with scale and technical certification gets both price discipline and better mix, so incremental EBITDA can outgrow revenue for several quarters. That makes the current setup more about estimate revisions and backlog durability than about near-term headline growth.

The second-order winner is Prysmian’s balance sheet. Falling leverage gives it optionality to preempt smaller rivals on capacity, bid more aggressively for long-duration projects, and use M&A to buy localized manufacturing or installation capabilities rather than waiting for organic expansion. The likely losers are regional cable players and project-focused competitors with weaker procurement power; they face a tougher pricing environment just as customers are willing to pay up for supply certainty.

Risk is mainly timing, not thesis. If hyperscaler capex pauses for a quarter, the stock could de-rate quickly because the equity is now pricing a cleaner 2026-27 path; copper price deflation and inventory normalization could also mask underlying demand. The contrarian point: consensus may be treating this as a linear AI beneficiary, but the real upside is in bottleneck economics—if lead times shorten or new capacity arrives, margin expansion could flatten even while volumes stay healthy.

More News